Subarachnoid buprenorphine administered by implantable micropumps.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 2305652.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This report concerns 23 patients, the majority of whom are suffering from low back and chest pain caused by chest, urological or gynaecological cancer. These patients were treated with subarachnoid buprenorphine, administered in a single bolus or by slow infusion from micropumps, at a daily dose adapted to patients need (0.06-0.15 mg). The painful symptomatology was successfully controlled in all the cases treated, allowing the patients to live a virtually normal life. In no cases was respiratory depression or tolerance observed.
Medical subject headings
- Buprenorphine
- Infusion Pumps, Implantable
- Intractable Pain